"10.1371_journal.pone.0040894","plos one","2012-07-27T00:00:00Z","Giovanni Cizza; Sima Mistry; Vi T Nguyen; Farideh Eskandari; Pedro Martinez; Sara Torvik; James C Reynolds; Philip W Gold; Ninet Sinai; Gyorgy Csako; for the POWER Study Group","Section on Neuroendocrinology of Obesity, National Institutes of Diabetes and Digestive Kidney Diseases (NIDDK), National Institutes of Health, Bethesda, Maryland, United States of America; Tulane University Internal Medicine-Pediatrics Residency Program, Tulane University School of Medicine, New Orleans, Louisiana, United States of America; Behavioral Endocrinology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland, United States of America; Clinical Center, National Institutes of Health, Bethesda, Maryland, United States of America","Conceived and designed the experiments: G. Cizza PWG G. Csako. Performed the experiments: G. Cizza FE PM ST JCR. Analyzed the data: G. Cizza SM VTN FE ST NS G. Csako. Wrote the paper: G. Cizza SM PM ST G. Csako.","Alendronate and Placebo were generously provided by Merck Research Laboratories, Rahway, NJ. The informatics support for this study was provided by Mr. Frank Pierce from Â®Esprit Health. Giovanni Cizza was a former Merck Employee and currently owns Merck stock options. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2012","07","Giovanni Cizza","GC",11,TRUE,1,1,1,1,TRUE,TRUE,TRUE,7,"2;3;4;5;6;7;9",TRUE
